Evidence map›Paper›PMID 25699711›Full record

ArticleMolecular cell2015

Zic2 is an enhancer-binding factor required for embryonic stem cell specification.

Zhuojuan Luo, Xin Gao, Chengqi Lin, Edwin R Smith, Stacy A Marshall, Selene K Swanson, Laurence Florens, Michael P Washburn, Ali Shilatifard

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Ablation ofPNAS nexus · 2023
    Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zhuojuan LuoStowers Institute for Medical Research, 1000 East 50(th) Street, Kansas City, MO 64110, USA.
Xin GaoStowers Institute for Medical Research, 1000 East 50(th) Street, Kansas City, MO 64110, USA.
Chengqi LinStowers Institute for Medical Research, 1000 East 50(th) Street, Kansas City, MO 64110, USA.
Edwin R SmithStowers Institute for Medical Research, 1000 East 50(th) Street, Kansas City, MO 64110, USA; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, 320 East Superior Street, Chicago, IL 60611, USA.
Stacy A MarshallStowers Institute for Medical Research, 1000 East 50(th) Street, Kansas City, MO 64110, USA.
Selene K SwansonStowers Institute for Medical Research, 1000 East 50(th) Street, Kansas City, MO 64110, USA.
Laurence FlorensStowers Institute for Medical Research, 1000 East 50(th) Street, Kansas City, MO 64110, USA.
Michael P WashburnStowers Institute for Medical Research, 1000 East 50(th) Street, Kansas City, MO 64110, USA; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Ali ShilatifardStowers Institute for Medical Research, 1000 East 50(th) Street, Kansas City, MO 64110, USA; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, 320 East Superior Street, Chicago, IL 60611, USA. Electronic address: ash@northwestern.edu.
Stowers Institute for Medical Research · USNorthwestern University · US

Funding

Chromatin Modifications by Histone Ubiquitination and MethylationsR01GM069905 · NIGMS · STOWERS INSTITUTE FOR MEDICAL RESEARCH · PI SHILATIFARD, ALI · 2004 to 2015
$4.7M
Physiological Role of MLL and ELL Proteins in LeukemiaR01CA089455 · NCI · STOWERS INSTITUTE FOR MEDICAL RESEARCH · PI SHILATIFARD, ALI · 2001 to 2015
$3.5M
Transcriptional Elongation Control in Development and DiseaseR01CA214035 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SHILATIFARD, ALI · 2016 to 2020
$3.0M
NCI NIH HHS R01 CA089455NCI NIH HHS R01 CA214035NCI NIH HHS R01CA89455NIGMS NIH HHS R01 GM069905NIGMS NIH HHS R01GM069905
6 · The paper itself

Abstract

The Zinc-finger protein of the cerebellum 2 (Zic2) is one of the vertebrate homologs of the Drosophila pair-rule gene odd-paired (opa). Our molecular and biochemical studies demonstrate that Zic2 preferentially binds to transcriptional enhancers and is required for the regulation of gene expression in embryonic stem cells. Detailed genome-wide and molecular studies reveal that Zic2 can function with Mbd3/NuRD in regulating the chromatin state and transcriptional output of genes linked to differentiation. Zic2 is required for proper differentiation of embryonic stem cells (ESCs), similar to what has been previously reported for Mbd3/NuRD. Our study identifies Zic2 as a key factor in the execution of transcriptional fine-tuning with Mbd3/NuRD in ESCs through interactions with enhancers. Our study also points to the role of the Zic family of proteins as enhancer-specific binding factors functioning in development.

Indexed as

Cell DifferentiationAnimalsDNA-Binding ProteinsEmbryonic Stem CellsEnhancer Elements, GeneticGene Expression RegulationMi-2 Nucleosome Remodeling and Deacetylase ComplexMiceTranscription FactorsTranscription, GeneticDNA-Binding ProteinsMbd3 protein, mouseMi-2 Nucleosome Remodeling and Deacetylase ComplexTranscription FactorsZic2 protein, mouse

Identifiers

PMID25699711
PMCPMC5009765
OpenAlexW2061329687

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.